WALD WALDENCAST ACQUISITION CORP

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.

On Tuesday, August 27, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the second quarter and first half of fiscal 2024. The Company’s management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Wednesday, August 28, 2024 at 8:30am ET.

On Wednesday, November 20, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the third quarter and first nine months of fiscal 2024. The Company’s management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Thursday, November 21, 2024 at 8:30am ET.

Conference call dial in and webcast details will be added to the events section of the Company's investor relations website at  approximately 2 weeks prior to the earnings date.

About Waldencast

Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Skincare and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: /.

Contacts

Investors

ICR

Allison Malkin

Media

ICR

Brittney Fraser/Alecia Pulman



EN
27/06/2024

Underlying

WALDWALDENCAST ACQUISITION CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WALDENCAST ACQUISITION CORP

 PRESS RELEASE
Free
WALD WALDENCAST ACQU...

Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA...

Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic practices nationwide NEW YORK and IRVING, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announce...

February 17, 2026 1 EN
 PRESS RELEASE
Free
WALD WALDENCAST ACQU...

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program t...

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices NEW YORK and SUNSET BEACH, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced DermFx as a key partner for the Aesthet...

February 6, 2026 1 EN
 PRESS RELEASE
Free
WALD WALDENCAST ACQU...

Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to...

Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic entrepreneurs NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Moxie as a strategic partner in the Aesthetics Leadership with Obagi’s Hyaluronic A...

February 5, 2026 1 EN
 PRESS RELEASE
Free
WALD WALDENCAST ACQU...

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurfac...

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), continues its commitment to advanced skin science with the launch of two new lip innovations designed to work together as a targeted treatmen...

February 3, 2026 1 EN
 PRESS RELEASE
Free
WALD WALDENCAST ACQU...

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Prog...

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care NEW YORK and STRONGSVILLE, Ohio, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced VIO Med Spa as a launch partner for the Aesthetics Leadership wit...

January 30, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch